Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1678660 · PRLD

Prelude Therapeutics Inc

Filing with the SEC SEC-reporting company Wilmington, DE Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Net loss in 2025Net loss of $99.5M for the year (2024: −$127M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$12.1M$7M
Net income (loss)−$99.5M−$127M
Total assets$141M$176M
Total liabilities$72.7M$44.1M
Stockholders’ equity$68.6M$131M
Cash and equivalents$35.3M$12.5M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Prelude Therapeutics Inc
Formerly: Prelude Therapeutics Inc.
CIK
0001678660
Tickers
PRLD
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Wilmington, Delaware
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 16, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 16, 2026 · filing · edition of Nov 16, 2026
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 16, 2026 · filing · edition of Nov 16, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 11, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 11, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 12, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 12, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Apr 15, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Mar 10, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 10, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 12, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.02, 7.01, 9.01 · filed Nov 4, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01 · filed Oct 17, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 14, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07 · filed Jun 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 6, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Mar 28, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Mar 10, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 10, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Feb 5, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 6, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 6, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 12, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 7, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 7, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Apr 10, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 15, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Feb 15, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 1, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 1, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 3, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 3, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 8, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 8, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 8.01, 9.01 · filed Mar 15, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 15, 2023 · filing